VICTOR: A phase III placebo-controlled trial of rofecoxib in colorectal cancer patients following surgical resection

Схожие документы

• VICTOR: A PHASE III PLACEBO-CONTROLLED TRIAL OF ROFECOXIB IN COLORECTAL CANCER PATIENTS FOLLOWING SURGICAL RESECTION
  по: Midgley, R, и др.
  Опубликовано: (2008)
• Phase III randomized trial assessing rofecoxib in the adjuvant setting of colorectal cancer: final results of the VICTOR trial.
  по: Midgley, R, и др.
  Опубликовано: (2010)
• Rofecoxib and cardiovascular adverse events in adjuvant treatment of colorectal cancer.
  по: Kerr, D, и др.
  Опубликовано: (2007)
• The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: validation in the VICTOR trial.
  по: Huijbers, A, и др.
  Опубликовано: (2013)
• Rofecoxib Induced Purpura
  по: Dogra Sunil, и др.
  Опубликовано: (2004-01-01)